303 related articles for article (PubMed ID: 26676906)
1. Associations among serum trimethylamine-N-oxide (TMAO) levels, kidney function and infarcted coronary artery number in patients undergoing cardiovascular surgery: a cross-sectional study.
Mafune A; Iwamoto T; Tsutsumi Y; Nakashima A; Yamamoto I; Yokoyama K; Yokoo T; Urashima M
Clin Exp Nephrol; 2016 Oct; 20(5):731-739. PubMed ID: 26676906
[TBL] [Abstract][Full Text] [Related]
2. Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events.
Kim RB; Morse BL; Djurdjev O; Tang M; Muirhead N; Barrett B; Holmes DT; Madore F; Clase CM; Rigatto C; Levin A;
Kidney Int; 2016 May; 89(5):1144-1152. PubMed ID: 27083288
[TBL] [Abstract][Full Text] [Related]
3. Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden.
Stubbs JR; House JA; Ocque AJ; Zhang S; Johnson C; Kimber C; Schmidt K; Gupta A; Wetmore JB; Nolin TD; Spertus JA; Yu AS
J Am Soc Nephrol; 2016 Jan; 27(1):305-13. PubMed ID: 26229137
[TBL] [Abstract][Full Text] [Related]
4. Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease.
Missailidis C; Hällqvist J; Qureshi AR; Barany P; Heimbürger O; Lindholm B; Stenvinkel P; Bergman P
PLoS One; 2016; 11(1):e0141738. PubMed ID: 26751065
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease.
Tang WH; Wang Z; Kennedy DJ; Wu Y; Buffa JA; Agatisa-Boyle B; Li XS; Levison BS; Hazen SL
Circ Res; 2015 Jan; 116(3):448-55. PubMed ID: 25599331
[TBL] [Abstract][Full Text] [Related]
6. Plasma Trimethylamine N-Oxide, a Gut Microbe-Generated Phosphatidylcholine Metabolite, Is Associated With Atherosclerotic Burden.
Senthong V; Li XS; Hudec T; Coughlin J; Wu Y; Levison B; Wang Z; Hazen SL; Tang WH
J Am Coll Cardiol; 2016 Jun; 67(22):2620-8. PubMed ID: 27256833
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal Plasma Measures of Trimethylamine N-Oxide and Risk of Atherosclerotic Cardiovascular Disease Events in Community-Based Older Adults.
Lee Y; Nemet I; Wang Z; Lai HTM; de Oliveira Otto MC; Lemaitre RN; Fretts AM; Sotoodehnia N; Budoff M; DiDonato JA; McKnight B; Tang WHW; Psaty BM; Siscovick DS; Hazen SL; Mozaffarian D
J Am Heart Assoc; 2021 Sep; 10(17):e020646. PubMed ID: 34398665
[TBL] [Abstract][Full Text] [Related]
8. Plasma Trimethylamine N-Oxide as a Novel Biomarker for Plaque Rupture in Patients With ST-Segment-Elevation Myocardial Infarction.
Tan Y; Sheng Z; Zhou P; Liu C; Zhao H; Song L; Li J; Zhou J; Chen Y; Wang L; Qian H; Sun Z; Qiao S; Xu B; Gao R; Yan H
Circ Cardiovasc Interv; 2019 Jan; 12(1):e007281. PubMed ID: 30599768
[TBL] [Abstract][Full Text] [Related]
9. Relationship between Plasma Trimethylamine N-Oxide Levels and Renal Dysfunction in Patients with Hypertension.
Zhou J; Wang D; Li B; Li X; Lai X; Lei S; Li N; Zhang X
Kidney Blood Press Res; 2021; 46(4):421-432. PubMed ID: 34233325
[TBL] [Abstract][Full Text] [Related]
10. Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control.
Mueller DM; Allenspach M; Othman A; Saely CH; Muendlein A; Vonbank A; Drexel H; von Eckardstein A
Atherosclerosis; 2015 Dec; 243(2):638-44. PubMed ID: 26554714
[TBL] [Abstract][Full Text] [Related]
11. Relation of Circulating Trimethylamine N-Oxide With Coronary Atherosclerotic Burden in Patients With ST-segment Elevation Myocardial Infarction.
Sheng Z; Tan Y; Liu C; Zhou P; Li J; Zhou J; Chen R; Chen Y; Song L; Zhao H; Yan H
Am J Cardiol; 2019 Mar; 123(6):894-898. PubMed ID: 30594289
[TBL] [Abstract][Full Text] [Related]
12. Circulating trimethylamine N-oxide is correlated with high coronary artery atherosclerotic burden in individuals with newly diagnosed coronary heart disease.
Bao M; Li H; Li J
BMC Cardiovasc Disord; 2024 May; 24(1):265. PubMed ID: 38773380
[TBL] [Abstract][Full Text] [Related]
13. Gut Microbiota-Dependent Trimethylamine N-oxide and Cardiovascular Outcomes in Patients With Prior Myocardial Infarction: A Nested Case Control Study From the PEGASUS-TIMI 54 Trial.
Gencer B; Li XS; Gurmu Y; Bonaca MP; Morrow DA; Cohen M; Bhatt DL; Steg PG; Storey RF; Johanson P; Wang Z; Hazen SL; Sabatine MS
J Am Heart Assoc; 2020 May; 9(10):e015331. PubMed ID: 32366163
[TBL] [Abstract][Full Text] [Related]
14. Utility of Plasma Concentration of Trimethylamine N-Oxide in Predicting Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes.
Winther SA; Øllgaard JC; Tofte N; Tarnow L; Wang Z; Ahluwalia TS; Jorsal A; Theilade S; Parving HH; Hansen TW; Hazen SL; Pedersen O; Rossing P
Diabetes Care; 2019 Aug; 42(8):1512-1520. PubMed ID: 31123156
[TBL] [Abstract][Full Text] [Related]
15. Trimethylamine-N-oxide (TMAO) predicts fatal outcomes in community-acquired pneumonia patients without evident coronary artery disease.
Ottiger M; Nickler M; Steuer C; Odermatt J; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
Eur J Intern Med; 2016 Dec; 36():67-73. PubMed ID: 27567042
[TBL] [Abstract][Full Text] [Related]
16. Endothelium-Dependent and -Independent Vascular Function in Advanced Chronic Kidney Disease.
Kopel T; Kaufman JS; Hamburg N; Sampalis JS; Vita JA; Dember LM
Clin J Am Soc Nephrol; 2017 Oct; 12(10):1588-1594. PubMed ID: 28784655
[TBL] [Abstract][Full Text] [Related]
17. Trimethylamine N-Oxide and Mortality Risk in Patients With Peripheral Artery Disease.
Senthong V; Wang Z; Fan Y; Wu Y; Hazen SL; Tang WH
J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27792653
[TBL] [Abstract][Full Text] [Related]
18. Microbiota-Dependent Metabolite Trimethylamine N-Oxide and Coronary Artery Calcium in the Coronary Artery Risk Development in Young Adults Study (CARDIA).
Meyer KA; Benton TZ; Bennett BJ; Jacobs DR; Lloyd-Jones DM; Gross MD; Carr JJ; Gordon-Larsen P; Zeisel SH
J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27792658
[TBL] [Abstract][Full Text] [Related]
19. Intestinal Microbiota-Generated Metabolite Trimethylamine-N-Oxide and 5-Year Mortality Risk in Stable Coronary Artery Disease: The Contributory Role of Intestinal Microbiota in a COURAGE-Like Patient Cohort.
Senthong V; Wang Z; Li XS; Fan Y; Wu Y; Tang WH; Hazen SL
J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 27287696
[TBL] [Abstract][Full Text] [Related]
20. Association of trimethylamine N-oxide with coronary atherosclerotic burden in patients with non-ST-segment elevation myocardial infarction.
Bin Waleed K; Lu Y; Liu Q; Zeng F; Tu H; Wei Y; Xu S; Zhang Z; Rongfeng Y; Fan A; Altaf A; Chang J; Wang L
Medicine (Baltimore); 2020 Jul; 99(27):e20794. PubMed ID: 32629663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
